Eli Lilly’s Antibody Treatment Proves Unhelpful for Advanced COVID Cases

A paused clinical trial of an Eli Lilly & Co. experimental antibody therapy won’t resume after federal researchers concluded the drug likely wouldn’t help hospitalized Covid-19 patients with advanced cases.

Learn more.

Source: National Hemophilia Foundation